Healthcare Industry News 31 December 2025

Johnson & Johnson stock ticks up on lupus drug data as earnings loom

New York, January 6, 2026, 12:58 EST — Regular session Johnson & Johnson (JNJ.N) shares rose on Tuesday after the company reported positive mid-stage data for its experimental lupus drug nipocalimab and outlined plans for late-stage testing. The stock was

6 January 2026

Biotech News·Earnings Reports·Healthcare Industry·Pharmaceuticals·Stock Market

Eli Lilly stock rises on Nimbus obesity pill pact as oral drug race heats up

New York, January 6, 2026, 10:55 EST — Regular session Eli Lilly and Company (LLY) shares rose about 1.6% on Tuesday after Nimbus Therapeutics announced a research and licensing agreement with the drugmaker aimed at developing an oral obesity treatment.

6 January 2026

Business News·Healthcare Industry·Pharmaceuticals·Stock Market

Pfizer stock in the spotlight: what to watch ahead of CEO Bourla’s JPM Healthcare Conference webcast

New York, January 5, 2026, 21:51 EST — Market closed Pfizer said it will webcast a discussion with Chief Executive Albert Bourla at the J.P. Morgan Healthcare Conference next week, putting the drugmaker’s 2026 reset back in focus. Pfizer shares

6 January 2026

Healthcare Industry·Investment Insights·Pharmaceuticals·Stock Market

Merck stock ticks higher as MRK nears recent highs ahead of JPM Healthcare Conference

New York, January 5, 2026, 15:35 EST — Regular session Merck & Co (NYSE:MRK) shares edged up on Monday as investors looked ahead to the drugmaker’s appearance at the annual J.P. Morgan Healthcare Conference next week. The stock was up

5 January 2026

Financial Analysis·Healthcare Industry·Investment News·Pharmaceuticals·Stock Market

Why Xenon Pharmaceuticals stock is down today as JPM Healthcare Conference nears

New York, January 5, 2026, 15:22 EST — Regular session Xenon Pharmaceuticals Inc (XENE) shares were down 6.5% at $41.60 in afternoon trading on Monday, about 8% off the session high. The Nasdaq-listed biotech traded between $45.21 and $41.45, with

5 January 2026

Financial Analysis·Healthcare Industry·Investment News·Pharmaceuticals·Stock Market

BridgeBio Pharma (BBIO) stock sinks 7% as JPM conference nears and achondroplasia catalyst looms

New York, January 5, 2026, 14:30 (EST) — Regular session BridgeBio Pharma shares slid 7.5% to $72.34 in afternoon trading on Monday after opening at $78.44 and touching $79.24 earlier in the session. The drop outpaced a roughly 2.2% decline

5 January 2026

Biotechnology·Healthcare Industry·Investment Analysis·Pharma News·Stock Market

Wave Life Sciences stock drops 8% as JPM Healthcare Conference looms; obesity data in focus

New York, January 5, 2026, 1:09 PM ET — Regular session Wave Life Sciences Ltd shares fell $1.34, or 8.4%, to $14.61 in afternoon trade on Monday, extending a sharp pullback in the clinical-stage biotech even as the company flagged

5 January 2026

Biotech News·Healthcare Industry·Investment Analysis·Stock Market

Eli Lilly stock slides as Novo’s Wegovy pill hits U.S. shelves and stokes obesity-drug pricing fears

New York, January 5, 2026, 10:58 (ET) — Regular session Eli Lilly and Company shares fell about 3.4% on Monday, extending early losses after rival Novo Nordisk began selling a pill version of its Wegovy weight-loss drug in the United

5 January 2026

Drug Pricing·Healthcare Industry·Pharmaceuticals·Stock Market

Merck stock in focus before Monday: Cidara deal deadline hits Jan. 6 as MRK sits near 52-week high

NEW YORK, Jan 4, 2026, 20:43 ET — Market closed Merck & Co shares closed up 1.1% on Friday at $106.45, leaving the stock within sight of a 52-week high ahead of Monday’s U.S. market reopen. MarketWatch The near-term focus

5 January 2026

Healthcare Industry·Investment News·Pharmaceuticals·Stock Market

INBS stock jumps on Syrma Johari deal: Intelligent Bio Solutions targets 40% cost cuts

NEW YORK, December 31, 2025, 5:04 PM ET — After-hours Shares of Intelligent Bio Solutions Inc more than doubled in Wednesday’s regular session as investors piled into the micro-cap medical technology stock on a fresh manufacturing update. The stock closed

31 December 2025

Business News·Healthcare Industry·Investment Strategies·Stock Market

Alignment Healthcare stock rises today despite new insider-sale filings, with ALHC near $20

NEW YORK, December 31, 2025, 14:50 ET — Regular session Alignment Healthcare, Inc. shares rose about 3.4% to $19.90 in mid-afternoon trading on Wednesday, after earlier touching $19.93 as the stock fluctuated between $18.83 and $19.93. The move came as

31 December 2025

Healthcare Industry·Insider Trading·Investment News·Stock Market

UHS stock sinks today after CEO contract extension filing — here’s what moved the shares

NEW YORK, December 31, 2025, 13:23 ET — Regular session Universal Health Services, Inc. shares were down 2.75% at $218.87 in afternoon trading on Wednesday, extending losses as the hospital operator underperformed its peer group. The stock was down $6.19

31 December 2025

Company Analysis·Financial Updates·Healthcare Industry·Stock Market

Healthcare Industry News 31 December 2025 - 6 January 2026